Cargando…

Association between transfusion status and clinical and economic outcomes in patients with myelodysplastic syndromes from the physicians' perspective

BACKGROUND: The current study investigated physicians' understanding of the impact of transfusion status (TS) on clinical and economic outcomes in patients with myelodysplastic syndromes (MDS). MATERIALS & METHODS: 378 physicians primarily specializing in hematology/oncology across five Eur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gupta, Shaloo, Kulasekararaj, Austin G., Costantino, Halley, Grisolano, Jay, Tang, Jackson, Jones, Shalon, Tang, Derek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9875619/ https://www.ncbi.nlm.nih.gov/pubmed/35942648 http://dx.doi.org/10.1002/cnr2.1680

Ejemplares similares

Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients’ Perspective
por: Knoth, Russell L., et al.
Publicado: (2023)

The Role of Real-World Evidence in UK Reimbursement: Case Study of Lenalidomide in Myelodysplastic Syndrome Deletion 5q
por: Lee, Dawn, et al.
Publicado: (2018)

Characterizing Outcomes and Unmet Needs Among Patients in the United States with Mild-to-Moderate Plaque Psoriasis Using Prescription Topicals
por: Gupta, Shaloo, et al.
Publicado: (2021)

Myelodysplastic Syndrome with Transfusion Dependence Treated with Venetoclax
por: Jehangir, Waqas, et al.
Publicado: (2020)

Immunogenicity of Covid-19 Vaccination in Subjects with Myelodysplastic Syndromes
por: Vidler, Jennifer, et al.
Publicado: (2021)

Transfusion Thresholds, Quality of Life, and Current Approaches in Myelodysplastic Syndromes
por: Koutsavlis, Ioannis
Publicado: (2016)

Assessing health status in informal schizophrenia caregivers compared with health status in non-caregivers and caregivers of other conditions
por: Gupta, Shaloo, et al.
Publicado: (2015)

Magnetic Resonance Myocardial Feature Tracking in Transfusion-Dependent Myelodysplastic Syndrome
por: Alonso-Fernandez-Gatta, Marta, et al.
Publicado: (2021)

The humanistic and economic burden associated with increasing body mass index in the EU5
por: Gupta, Shaloo, et al.
Publicado: (2015)

Longer-term benefit of luspatercept in transfusion-dependent lower-risk myelodysplastic syndromes with ring sideroblasts
por: Zeidan, Amer M., et al.
Publicado: (2022)

The Effect of Roxadustat on Transfusion-Dependent Myelodysplastic Syndrome Complicated by Chronic Kidney Disease
por: Hara, Ryujiro, et al.
Publicado: (2021)

Preclinical modeling of myelodysplastic syndromes
por: Rouault-Pierre, K, et al.
Publicado: (2017)

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
por: Alkhatabi, Heba A., et al.
Publicado: (2016)

P1059: REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION IN MYELOFIBROSIS PATIENTS WITH ANEMIA
por: Mascarenhas, John, et al.
Publicado: (2023)

PB2011: TRANSFUSION BURDEN IS AN IMPORTANT PROGNOSTIC FACTOR IN LOWER-RISK MYELODYSPLASTIC SYNDROME
por: Lee, Jungmin, et al.
Publicado: (2023)

Setting Physicians' Prices in FFS Medicare: An Economic Perspective
por: Dowd, Bryan, et al.
Publicado: (2006)

Patient-Physician Communication in Acute Myeloid Leukemia and Myelodysplastic Syndrome
por: Morelli, Emanuela, et al.
Publicado: (2021)

Expansion of myeloid derived suppressor cells correlates with number of T regulatory cells and disease progression in myelodysplastic syndrome
por: Kittang, Astrid Olsnes, et al.
Publicado: (2015)

Red Blood Cell Transfusion Independence Following the Initiation of Iron Chelation Therapy in Myelodysplastic Syndrome
por: Badawi, Maha A., et al.
Publicado: (2010)

Transfusion-dependent low-risk myelodysplastic patients receiving deferasirox: Long-term follow-up
por: IMPROTA, SALVATORE, et al.
Publicado: (2013)

Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome
por: de Montalembert, Mariane, et al.
Publicado: (2017)

Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study
por: Rozema, Johanne, et al.
Publicado: (2021)

Patterns of Diagnostic Evaluation and Determinants of Treatment in Older Patients With Non-transfusion Dependent Myelodysplastic Syndromes
por: Mukherjee, Sudipto, et al.
Publicado: (2023)

S169: MODULATION OF THE IMMUNE LANDSCAPE IN LOWER-RISK MYELODYSPLASTIC SYNDROMES WITH IMETELSTAT-INDUCED TRANSFUSION INDEPENDENCY
por: Chapuis, Nicolas, et al.
Publicado: (2023)

P1741: EXAMINING THE BURDEN OF ILLNESS ASSOCIATED WITH TRANSFUSION-DEPENDENT ΒETA-THALASSEMIA FROM THE PATIENT’S PERSPECTIVE
por: Knoth, R. L., et al.
Publicado: (2022)

Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia
por: Fattizzo, Bruno, et al.
Publicado: (2021)

Humanistic and economic burden associated with depression in the United States: a cross-sectional survey analysis
por: Jain, Saundra, et al.
Publicado: (2022)

Economic burden in the management of transfusion-dependent thalassaemia patients in Malaysia from a societal perspective
por: Shafie, Asrul Akmal, et al.
Publicado: (2021)

Assessment of factors influencing physicians’ intention to prescribe transfusion using the theory of planned behavior
por: Liao, Yu-Han, et al.
Publicado: (2023)

The Humanistic and Economic Burden of Migraine in Europe: A Cross-Sectional Survey in Five Countries
por: Doane, Michael J., et al.
Publicado: (2020)

BNT162b2 COVID-19 and ChAdOx1 nCoV-19 vaccination in patients with myelodysplastic syndromes
por: Abdul-Jawad, Sultan, et al.
Publicado: (2022)

Red cell alloimmunization is associated with development of autoantibodies and increased red cell transfusion requirements in myelodysplastic syndrome
por: Singhal, Deepak, et al.
Publicado: (2017)

Cardiac and hepatic siderosis in myelodysplastic syndrome, thalassemia and diverse causes of transfusion-dependent anemia: the TIMES study
por: Ho, P. Joy, et al.
Publicado: (2019)

Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study
por: Zhao, Jingcheng, et al.
Publicado: (2020)

Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes
por: Zeidner, Joshua F., et al.
Publicado: (2022)

Association of hypoglycaemia severity with clinical, patient‐reported and economic outcomes in US patients with type 2 diabetes using basal insulin
por: Meneghini, Luigi F., et al.
Publicado: (2018)

Evaluating the health and economic impact of osteoarthritis pain in the workforce: results from the National Health and Wellness Survey
por: DiBonaventura, Marco daCosta, et al.
Publicado: (2011)

Current status of transfusion services
por: Jolly, J. G.
Publicado: (2007)

P1677: DEFINING KEY QUALITY OF LIFE METRICS IN ACUTE MYELOID LEUKAEMIA AND HIGH RISK MYELODYSPLASTIC SYNDROME PATIENTS ENROLLED IN LARGE-SCALE UK NCRI AML TRIALS
por: Krishnamurthy, Pramila, et al.
Publicado: (2023)

Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial
por: Hsu, Peter, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rfkcn2phiq84tevdaq1881tjj8